Fatigue News and Research

RSS

Study shows physical activity helps people with osteoarthritis to walk faster

When a traffic light at a busy intersection flashes the WALK sign, people with knee osteoarthritis worry they can't walk fast enough to make it across the street in time. New Northwestern Medicine research shows people with this common arthritis are more likely to walk fast enough if they lead physically active lives.

19 Jan 2011

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

Genentech, a member of the Roche Group, today announced that BRIM3, a Phase III clinical study of RG7204, met its co-primary endpoints showing a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma.

19 Jan 2011

More studies needed to evaluate harm or benefit of mechanical CPR

Pushing on the chest to simulate the heart's rhythmic pumping action is an essential part of cardiopulmonary resuscitation after cardiac arrest. In recent decades, manufacturers have developed several mechanical devices that claim to perform CPR more effectively than human efforts alone.

19 Jan 2011

Heart failure patients admitted to general wards fare poorly: Study

The latest research shows that patients with heart failure are twice as likely to die if they are admitted to a general hospital ward rather than one specializing in cardiology. Heart failure kills nearly a quarter of a million people in England and Wales every year and about 900,000 people in the UK have the condition that means the heart is weakened and cannot pump blood efficiently. Symptoms include fatigue, breathlessness and swollen ankles, and it can lead to premature death.

18 Jan 2011

New study finds nurses' work schedule can impact patient outcomes

A new study has found that patient deaths from pneumonia and acute myocardial infarction were significantly more likely in hospitals where nurses reported schedules with long work hours.

18 Jan 2011

Addition of caffeine to alcohol does not improve sustained attention or reaction times

Marketing efforts that encourage mixing caffeinated "energy" drinks with alcohol often try to sway young people to believe that caffeine will offset the sedating effects of alcohol and increase alertness and stamina.

13 Jan 2011

Lightning Process training course tops in survey by ME/ CFS

A revolutionary self training course has emerged top in a survey conducted by the Sussex and Kent ME/ CFS Society.

12 Jan 2011

Shionogi brings KAPVAY ADHD drug to the U.S market

Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.

10 Jan 2011

Quality of life measures most useful for clinical decision-making in trials with QOL as primary outcome

Quality of life measures tend to be most useful for clinical decision-making in trials in which quality of life is the primary outcome, according to a recent study published online January 7 in The Journal of the National Cancer Institute.

10 Jan 2011

Tips for surviving a bout with 'stomach flu'

A post-holiday crush of patients are crowding into area physician offices and hospital emergency rooms as individuals of all ages suddenly find themselves laid low by a highly contagious and quick-striking virus.

10 Jan 2011

Pharmasset reports positive data from PSI-7977 and PSI-938 HCV clinical programs

Pharmasset, Inc., announced today positive data from interim analyses of two of its clinical programs: the HCV genotype 2 or 3 (GT2/3) arm of the PSI-7977 Phase 2b trial and the 14 day PSI-938 monotherapy cohort of the dual nucleotide study.

7 Jan 2011

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Colorectal cancer (CRC) is the third most common cancer in men and women in the USA, with a new diagnosis made every 3.5 minutes and an associated death every 9 minutes.

6 Jan 2011

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Sanofi-aventis and its wholly-owned subsidiary, BiPar Sciences, today announced that The New England Journal of Medicine published the final phase II data for the investigational drug iniparib demonstrating significant clinical benefit in women with metastatic triple negative breast cancer when iniparib was administered in combination with chemotherapy agents gemcitabine/carboplatin.

6 Jan 2011

AOA says 3D viewing may help uncover vision disorders in children

The American Optometric Association, representing America's family eye doctors, says 3D in movies, TV and even 3D on Nintendo's 3DS isn't necessarily bad for adults or children.

6 Jan 2011

Study reviews effects of supplements on mental energy

The Life Sciences Research Organization, Inc. (LSRO) has published a review article in the December 2010 issue of Nutrition Reviews entitled Do Specific Constituents and Supplements Affect Mental Energy? Review of the Evidence.

5 Jan 2011

FDA approves ImmunoCellular Therapeutics IND amendment for ICT-107 Phase II clinical trial

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) amendment to conduct a Phase II clinical trial in the U.S. of ICT-107, the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).

4 Jan 2011

Hepatitis A scare at Long Island church

Health officials have warned that parishioners who received Holy Communion during Christmas Mass at a church on Long Island may have been exposed to hepatitis A and may need vaccinated as soon as possible. Particularly those who received Communion at the 10.30am and 12pm (local time) masses on December 25, 2010, at Our Lady of Lourdes Church in Massapequa Park should get the shots.

4 Jan 2011

Chest: January news briefs

New research suggests that subcutaneous omalizumab is safe and effective an add-on treatment to corticosteroids for moderate to severe asthma in children and adults. Researchers from Uruguay, Argentina, and Chile performed a meta-analysis on eight trials where 1,883 patients received omalizumab and 1,546 received a placebo.

4 Jan 2011

Tips to prevent a hangover

Dr. Andrew Yacht, director of the division of general medicine and vice chair of medicine for education at Maimonides Medical Center in New York City said, “Alcohol clearly causes hangovers, but why it causes hangovers isn’t very well understood…Part of the suspected cause is dehydration and an electrolyte and hormonal imbalance. Some of the symptoms may be caused by low blood sugar. Or, it may be that the direct toxic effects of alcohol are causing the symptoms.”

2 Jan 2011

Sleep-deprived physicians not to perform elective surgeries without patient's consent

While regulations have been put in place to restrict the work hours of doctors in training, no such regulations exist for fully trained physicians. An editorial in this week's New England Journal of Medicine argues that sleep-deprived physicians should not be permitted to proceed with an elective surgery without a patient's informed, written consent.

30 Dec 2010

Fatigue News and Research

Study shows physical activity helps people with osteoarthritis to walk faster

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

More studies needed to evaluate harm or benefit of mechanical CPR

Heart failure patients admitted to general wards fare poorly: Study

New study finds nurses' work schedule can impact patient outcomes

Addition of caffeine to alcohol does not improve sustained attention or reaction times

Lightning Process training course tops in survey by ME/ CFS

Shionogi brings KAPVAY ADHD drug to the U.S market

Quality of life measures most useful for clinical decision-making in trials with QOL as primary outcome

Tips for surviving a bout with 'stomach flu'

Pharmasset reports positive data from PSI-7977 and PSI-938 HCV clinical programs

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

AOA says 3D viewing may help uncover vision disorders in children

Study reviews effects of supplements on mental energy

FDA approves ImmunoCellular Therapeutics IND amendment for ICT-107 Phase II clinical trial

Hepatitis A scare at Long Island church

Chest: January news briefs

Tips to prevent a hangover

Sleep-deprived physicians not to perform elective surgeries without patient's consent

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News